, Decision_act (EU) 1980/1283

In forcesince 25 Nov 1980

Despite the January 1977 change the search for Mohringer's (Eurim Pharm's) source of supply was pursued. By letter of 19 January 1977 to Cilag Alsbach, Ortho UK confirmed that if an exporter were identified, the supply of Gravindex to the German market would be stopped.

21.

A definite identification of a British exporter was made in February 1977. By test purchase from Eurim Pharm, Cilag Alsbach Obtained possession of a Gravindex package which was specially identified by the batch number and also by a triangular piece cut out of the package insert (see letter from Cilag Alsbach to Ortho UK of 4 February 1977).

22.

Although Ortho UK should have been aware that the imposition on customers of a prohibition on exports to other EEC Member States would infringe the competition rules of the EEC Treaty (1), the Ortho UK company nevertheless substantially stopped supplies to certain chemists in May and June 1977, by totally withholding supplies or by drastically restricting them (see letters from Ortho UK to Cilag Alsbach dated 18 May and 11 July 1977). The letter of 18 May indicated four "possible methods" of stopping the trade of Gravindex slide tests from the UK into Germany. Firstly, as abovementioned, Ortho UK had stopped deliveries to certain dealers. (Quoting them : "However, this will probably only result in temporary sustaining the flow as other distributors might be approached".) A second possibility was to raise the UK price to a level close to that of the European selling price (again quoting "but our pricing laws in the UK will not allow us to do this"). Thirdly, Ortho UK might change the Gravindex trade mark. They wrote : "but this, yet again, would only lead to a temporary sustainance of the business, as I am sure that people would realize it was the same product". Fourthly, they might consider withdrawing the 20 test pack from the UK market completely.